Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Clinical trial NCT03872180 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03872180
- Sponsor
- Emory University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2022-06-06
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.